Rehabilitation Interventions in Adults with Amyotrophic Lateral Sclerosis: A Review
Rehabilitation in Adults with ALS
DOI:
https://doi.org/10.31661/gmj.vi.3708Keywords:
Amyotrophic Lateral Sclerosis; Rehabilitation; Exercise TherapyAbstract
Amyotrophic Lateral Sclerosis (ALS) is the most common and rapidly devastating neurodegenerative disease, which causes impairment of motor neurons in the upper and lower limbs, as well as in the bulbar muscles among adults. This leads to progressive weakness of voluntary muscles. The median survival after the emergence of initial symptoms is typically three years. During this period, due to the worsening of general well-being and independence, patients and their caregivers experience significant emotional stress. Furthermore, there is currently no definitive treatment for ALS. Consequently, patients face various challenges associated with motor impairment, including mobility disturbances, respiratory dysfunction, speech difficulties, and limitations in activities of daily living. Therefore, rehabilitation plays a vital role as a component of multidisciplinary care for managing these issues and reducing the impact of the disease on patients and their families. It is considered the optimal choice for alleviating the discomfort of ALS patients until a curative treatment is discovered.
This narrative review aims to provide an overview of different aspects of rehabilitation, including physical therapy, occupational therapy, speech therapy, and respiratory strategies focused on enhancing independence, functional abilities, and overall quality of life while minimizing disabilities and complications in patients coping with this debilitating condition.
References
Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377(2):162-72.
https://doi.org/10.1056/NEJMra1603471
PMid:28700839
Cunha-Oliveira T, Montezinho L, Mendes C, Firuzi O, Saso L, Oliveira PJ, et al. Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention. Oxid Med Cell Longev. 2020;2020:5021694.
https://doi.org/10.1155/2020/5021694
PMid:33274002 PMCid:PMC7683149
van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390(10107):2084-98.
https://doi.org/10.1016/S0140-6736(17)31287-4
PMid:28552366
Smith EF, Shaw PJ, De Vos KJ. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci Lett. 2019;710:132933.
https://doi.org/10.1016/j.neulet.2017.06.052
PMid:28669745
Cruz MP. Edaravone (Radicava): A Novel Neuroprotective Agent for the Treatment of Amyotrophic Lateral Sclerosis. P T. 2018;43(1):25-8.
Soriani MH, Desnuelle C. Care management in amyotrophic lateral sclerosis. Rev Neurol (Paris). 2017;173(5):288-99.
https://doi.org/10.1016/j.neurol.2017.03.031
PMid:28461024
Obrador E, Salvador R, López-Blanch R, Jihad-Jebbar A, Vallés SL, Estrela JM. Oxidative Stress, Neuroinflammation and Mitochondria in the Pathophysiology of Amyotrophic Lateral Sclerosis. Antioxidants (Basel). 2020;9(9):901.
https://doi.org/10.3390/antiox9090901
PMid:32971909 PMCid:PMC7555310
Tard C, Defebvre L, Moreau C, Devos D, Danel-Brunaud V. Clinical features of amyotrophic lateral sclerosis and their prognostic value. Rev Neurol (Paris). 2017;173(5):263-72.
https://doi.org/10.1016/j.neurol.2017.03.029
PMid:28477850
Gamskjaer T, Werlauff U, Handberg C. Investigating job satisfaction in palliative rehabilitation: Reflections and perspectives of health professionals working with amyotrophic lateral sclerosis. J Eval Clin Pract. 2022;28(1):108-19.
https://doi.org/10.1111/jep.13599
PMid:34269500
Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: A critical review. Amyotroph Lateral Scler. 2009;10(5-6):310-23.
https://doi.org/10.3109/17482960802566824
PMid:19922118 PMCid:PMC3515205
Silva JPR, Júnior JBS, Dos Santos EL, de Carvalho FO, de França Costa IMP, de Mendonça DMF. Quality of life and functional independence in amyotrophic lateral sclerosis: A systematic review. Neurosci Biobehav Rev. 2020;111:1-11.
https://doi.org/10.1016/j.neubiorev.2019.12.032
PMid:31917162
Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293-9.
https://doi.org/10.1080/146608200300079536
PMid:11464847
De Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008;119(3):497-503.
https://doi.org/10.1016/j.clinph.2007.09.143
PMid:18164242
Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K, et al. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2011;82(6):623-7.
https://doi.org/10.1136/jnnp.2010.224501
PMid:21047878
Battaglia G, Bruno V. Metabotropic glutamate receptor involvement in the pathophysiology of amyotrophic lateral sclerosis: new potential drug targets for therapeutic applications. Curr Opin Pharmacol. 2018;38:65-71.
https://doi.org/10.1016/j.coph.2018.02.007
PMid:29529498
Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Altamirano PF, et al. A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int. 2015;6:171.
https://doi.org/10.4103/2152-7806.169561
PMid:26629397 PMCid:PMC4653353
Ingre C, Roos PM, Piehl F, Kamel F, Fang F. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015:181-93.
https://doi.org/10.2147/CLEP.S37505
PMid:25709501 PMCid:PMC4334292
Pupillo E, Poloni M, Bianchi E, Giussani G, Logroscino G, Zoccolella S, et al. Trauma and amyotrophic lateral sclerosis: a european population-based case-control study from the EURALS consortium. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19(1-2):118-25.
https://doi.org/10.1080/21678421.2017.1386687
PMid:29063790
Logan R, Dubel-Haag J, Schcolnicov N, Miller SJ. Novel genetic signatures associated with sporadic amyotrophic lateral sclerosis. Front Genet. 2022;13:851496.
https://doi.org/10.3389/fgene.2022.851496
PMid:35401706 PMCid:PMC8986983
Chia R, Chio A, Traynor BJ. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol. 2018;17(1):94-102.
https://doi.org/10.1016/S1474-4422(17)30401-5
PMid:29154141
Duffy JR, Peach RK, Strand EA. Progressive apraxia of speech as a sign of motor neuron disease. AJA. 2007;16(3):198-208.
https://doi.org/10.1044/1058-0360(2007/025)
PMid:17666546
Kuwabara S, Sonoo M, Komori T, Shimizu T, Hirashima F, Inaba A, et al. Dissociated small hand muscle atrophy in amyotrophic lateral sclerosis: frequency, extent, and specificity. Muscle Nerve. 2008;37(4):426-30.
https://doi.org/10.1002/mus.20949
PMid:18236469
Riad SM, Hathout H, Huang JC. High T2 signal in primary lateral sclerosis supports the topographic distribution of fibers in the corpus callosum: assessing disease in the primary motor segment. AJNR Am J Neuroradiol. 2011;32(4):E61-4.
https://doi.org/10.3174/ajnr.A2067
PMid:20299433 PMCid:PMC7965866
Masrori P, Van Damme P. Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol. 2020;27(10):1918-29.
https://doi.org/10.1111/ene.14393
PMid:32526057 PMCid:PMC7540334
Ajroud-Driss S, Siddique T. Sporadic and hereditary amyotrophic lateral sclerosis (ALS). Biochim Biophys Acta. 2015;1852(4):679-84.
https://doi.org/10.1016/j.bbadis.2014.08.010
PMid:25193032
Ferguson TA, Elman LB. Clinical presentation and diagnosis of amyotrophic lateral sclerosis. NeuroRehabilitation. 2007;22(6):409-16.
https://doi.org/10.3233/NRE-2007-22602
Leigh PN, Abrahams S, Al-Chalabi A, Ampong MA, Goldstein LH, Johnson J, et al. The management of motor neurone disease. J Neurol Neurosurg Psychiatry. 2003;74 Suppl 4(Suppl 4):iv32-iv47.
Rabinstein AA, Wijdicks EF. Warning signs of imminent respiratory failure in neurological patients. Semin Neurol. 2003;23(1):97-104.
https://doi.org/10.1055/s-2003-40757
PMid:12870111
Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377(9769):942-55.
https://doi.org/10.1016/S0140-6736(10)61156-7
PMid:21296405
Parvizi J, Anderson SW, Martin CO, Damasio H, Damasio AR. Pathological laughter and crying: a link to the cerebellum. Brain. 2001;124(Pt 9):1708-19.
https://doi.org/10.1093/brain/124.9.1708
PMid:11522574
Garuti G, Rao F, Ribuffo V, Sansone VA. Sialorrhea in patients with ALS: current treatment options. Degener Neurol Neuromuscul Dis. 2019;9:19-26.
https://doi.org/10.2147/DNND.S168353
PMid:31118868 PMCid:PMC6498144
Danel-Brunaud V, Touzet L, Chevalier L, Moreau C, Devos D, Vandoolaeghe S, et al. Ethical considerations and palliative care in patients with amyotrophic lateral sclerosis: a review. Rev Neurol (Paris). 2017;173(5):300-7.
https://doi.org/10.1016/j.neurol.2017.03.032
PMid:28479121
Elamin M, Phukan J, Bede P, Jordan N, Byrne S, Pender N, et al. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology. 2011;76(14):1263-9.
https://doi.org/10.1212/WNL.0b013e318214359f
PMid:21464431
Dorst J, Ludolph AC, Huebers A. Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosis. Ther Adv Neurol Disord. 2018;11:1756285617734734.
https://doi.org/10.1177/1756285617734734
PMid:29399045 PMCid:PMC5784546
Ilieva H, Vullaganti M, Kwan J. Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis. Bmj. 2023;383:e075037.
https://doi.org/10.1136/bmj-2023-075037
PMid:37890889 PMCid:PMC10603569
Miller RG, Mitchell JD, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev. 2012;2012(3):CD001447.
https://doi.org/10.1002/14651858.CD001447.pub3
PMid:22419278
Deng Y, Xu Z, Xu B, Tian Y, Xin X, Deng X, et al. The protective effect of riluzole on manganese caused disruption of glutamate-glutamine cycle in rats. Brain Res. 2009;1289:106-17.
https://doi.org/10.1016/j.brainres.2009.07.012
PMid:19615351
Bensimon G, Lacomblez L, Delumeau JC, Bejuit R, Truffinet P, Meininger V, et al. A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis. J Neurol. 2002;249(5):609-15.
https://doi.org/10.1007/s004150200071
PMid:12021952
Tzeplaeff L, Wilfling S, Requardt MV, Herdick M. Current State and Future Directions in the Therapy of ALS. Cells. 2023;12(11):1523.
https://doi.org/10.3390/cells12111523
PMid:37296644 PMCid:PMC10252394
Schultz J. Disease-modifying treatment of amyotrophic lateral sclerosis. Am J Manag Care. 2018;24(15 Suppl):S327-S35.
Lejman J, Panuciak K, Nowicka E, Mastalerczyk A, Wojciechowska K, Lejman M. Gene Therapy in ALS and SMA: Advances, Challenges and Perspectives. Int J Mol Sci. 2023;24(2):1130.
https://doi.org/10.3390/ijms24021130
PMid:36674643 PMCid:PMC9860634
de Carvalho M, Nogueira A, Pinto A, Miguens J, Sales Luis ML. Reflex sympathetic dystrophy associated with amyotrophic lateral sclerosis. J Neurol Sci. 1999;169(1-2):80-3.
https://doi.org/10.1016/S0022-510X(99)00220-8
PMid:10540012
Assouline A, Levy A, Abdelnour-Mallet M, Gonzalez-Bermejo J, Lenglet T, Le Forestier N, et al. Radiation therapy for hypersalivation: a prospective study in 50 amyotrophic lateral sclerosis patients. Int J Radiat Oncol Biol Phys. 2014;88(3):589-95.
https://doi.org/10.1016/j.ijrobp.2013.11.230
PMid:24411632
Moore DH, Miller RG. Improving efficiency of ALS clinical trials using lead-in designs. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004; 5: 57-60.
https://doi.org/10.1080/17434470410019997
PMid:15512875
White LJ, Dressendorfer RH. Exercise and multiple sclerosis. Sports Med. 2004;34(15):1077-100.
https://doi.org/10.2165/00007256-200434150-00005
PMid:15575796
Majmudar S, Wu J, Paganoni S. Rehabilitation in amyotrophic lateral sclerosis: why it matters. Muscle Nerve. 2014;50(1):4-13.
https://doi.org/10.1002/mus.24202
PMid:24510737 PMCid:PMC4433000
Karam CY, Paganoni S, Joyce N, Carter GT, Bedlack R. Palliative Care Issues in Amyotrophic Lateral Sclerosis: An Evidenced-Based Review. Am J Hosp Palliat Care. 2016;33(1):84-92.
https://doi.org/10.1177/1049909114548719
PMid:25202033 PMCid:PMC4439378
Medicine ACoS. The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exerc. 1998;30:975-91.
https://doi.org/10.1249/00005768-199806000-00032
Tsitkanou S, Della Gatta P, Foletta V, Russell A. The role of exercise as a non-pharmacological therapeutic approach for amyotrophic lateral sclerosis: beneficial or detrimental? Front Neurol. 2019;10:783.
https://doi.org/10.3389/fneur.2019.00783
PMid:31379732 PMCid:PMC6652799
Clawson LL, Cudkowicz M, Krivickas L, Brooks BR, Sanjak M, Allred P, et al. A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19(3-4):250-8.
https://doi.org/10.1080/21678421.2017.1404108
PMid:29191052
Kato N, Hashida G, Konaka K. Effect of muscle strengthening exercise and time since onset in patients with amyotrophic lateral sclerosis: A 2-patient case series study. Medicine (Baltimore). 2018;97(25):e11145.
https://doi.org/10.1097/MD.0000000000011145
PMid:29924018 PMCid:PMC6024467
Psalidas CP, Kottaras A, Lytras D, Iakovidis P, Leptourgos G, Moutaftsis K. The role of therapeutic exercise as a means of intervention for the treatment of amyotrophic lateral sclerosis. Int J Adv Community Med. 2021;4(2):29-31.
https://doi.org/10.33545/comed.2021.v4.i2a.193
Strickland D, Smith SA, Dolliff G, Goldman L, Roelofs RI. Physical activity, trauma, and ALS: a case-control study. Acta Neurol Scand. 1996;94(1):45-50.
https://doi.org/10.1111/j.1600-0404.1996.tb00038.x
PMid:8874593
Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, Sufit R, et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology. 1999;52(7):1311-23.
https://doi.org/10.1212/WNL.52.7.1311
PMid:10227612
Harwood CA, McDermott CJ, Shaw PJ. Physical activity as an exogenous risk factor in motor neuron disease (MND): a review of the evidence. Amyotroph Lateral Scler. 2009;10(4):191-204.
https://doi.org/10.1080/17482960802549739
PMid:19263258
Harwood CA, Westgate K, Gunstone S, Brage S, Wareham NJ, McDermott CJ, et al. Long-term physical activity: an exogenous risk factor for sporadic amyotrophic lateral sclerosis? Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(5-6):377-84.
https://doi.org/10.3109/21678421.2016.1154575
PMid:26998882 PMCid:PMC4950417
Krivickas LS. Rehabilitation of Amyotrophic Lateral Sclerosis. Motor Neuron Disease. 2008:31.
https://doi.org/10.1016/B978-1-4160-4007-1.50127-9
Gruis KL, Lechtzin N. Respiratory therapies for amyotrophic lateral sclerosis: a primer. Muscle Nerve. 2012;46(3):313-31.
https://doi.org/10.1002/mus.23282
PMid:22907221
Miller RG, Brooks BR, Swain-Eng RJ, Basner RC, Carter GT, Casey P, et al. Quality improvement in neurology: amyotrophic lateral sclerosis quality measures: report of the quality measurement and reporting subcommittee of the American Academy of Neurology. Neurology. 2013;81(24):2136-40.
https://doi.org/10.1212/01.wnl.0000437305.37850.f9
PMid:24271651 PMCid:PMC3863352
Niedermeyer S, Murn M, Choi PJ. Respiratory Failure in Amyotrophic Lateral Sclerosis. Chest. 2019;155(2):401-8.
https://doi.org/10.1016/j.chest.2018.06.035
PMid:29990478
Ferreira GD, Costa AC, Plentz RD, Coronel CC, Sbruzzi G. Respiratory training improved ventilatory function and respiratory muscle strength in patients with multiple sclerosis and lateral amyotrophic sclerosis: systematic review and meta-analysis. Physiotherapy. 2016;102(3):221-8.
https://doi.org/10.1016/j.physio.2016.01.002
PMid:27026167
Plowman EK, Tabor-Gray L, Rosado KM, Vasilopoulos T, Robison R, Chapin JL, et al. Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham-controlled trial. Muscle Nerve. 2019;59(1):40-6.
https://doi.org/10.1002/mus.26292
PMid:29981250
Rafiq MK, Bradburn M, Proctor AR, Billings CG, Bianchi S, McDermott CJ, et al. A preliminary randomized trial of the mechanical insufflator-exsufflator versus breath-stacking technique in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(7-8):448-55.
https://doi.org/10.3109/21678421.2015.1051992
PMid:26140500
Tzelepis GE, Vega DL, Cohen ME, Fulambarker AM, Patel KK, McCool FD. Pressure-flow specificity of inspiratory muscle training. J Appl Physiol (1985). 1994;77(2):795-801.
https://doi.org/10.1152/jappl.1994.77.2.795
PMid:8002530
Tzelepis GE, Kadas V, McCool FD. Inspiratory muscle adaptations following pressure or flow training in humans. Eur J Appl Physiol Occup Physiol. 1999;79(6):467-71.
https://doi.org/10.1007/s004210050538
PMid:10344453
Silva IS, Pedrosa R, Azevedo IG, Forbes AM, Fregonezi GA, Dourado Junior ME, et al. Respiratory muscle training in children and adults with neuromuscular disease. Cochrane Database Syst Rev. 2019;9(9):CD011711.
https://doi.org/10.1002/14651858.CD011711.pub2
PMid:31487757
Cabrita B, Dias S, Fernandes AL, Correia S, Ferreira J, Simao P. Inspiratory muscle training in neuromuscular patients: Assessing the benefits of a novel protocol. J Back Musculoskelet Rehabil. 2021;34(4):537-43.
https://doi.org/10.3233/BMR-200141
PMid:33523039
Vicente-Campos D, Sanchez-Jorge S, Chicharro JL, Becerro-de Bengoa-Vallejo R, Rodriguez-Sanz D, Garcia AR, et al. POWERbreathe((R)) Inspiratory Muscle Training in Amyotrophic Lateral Sclerosis. J Clin Med. 2022;11(22):6655.
https://doi.org/10.3390/jcm11226655
PMid:36431132 PMCid:PMC9698064
Dubbioso R, Spisto M, Hausdorff JM, Aceto G, Iuzzolino VV, Senerchia G, et al. Cognitive impairment is associated with gait variability and fall risk in amyotrophic lateral sclerosis. Eur J Neurol. 2023;30(10):3056-67.
https://doi.org/10.1111/ene.15936
PMid:37335396
Lange DJ, Murphy PL, Maxfield RA, Skarvala A-M, Riedel G. Management of patients with amyotrophic lateral sclerosis. J Neurol Rehabil. 1994;8(2):75-82.
https://doi.org/10.1177/136140969400800204
Creemers H, Beelen A, Grupstra H, Nollet F, van den Berg LH. The provision of assistive devices and home adaptations to patients with ALS in the Netherlands: patients' perspectives. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(5-6):420-5.
https://doi.org/10.3109/21678421.2014.920031
PMid:24899120
Boostani R, Olfati N, Shamshiri H, Salimi Z, Fatehi F, Hedjazi SA, et al. Iranian clinical practice guideline for amyotrophic lateral sclerosis. Front Neurol. 2023;14:1154579.
https://doi.org/10.3389/fneur.2023.1154579
PMid:37333000 PMCid:PMC10272856
Lindenberger E, Meier DE. What Special Considerations Are Needed for Individuals With Amyotrophic Lateral Sclerosis, Multiple Sclerosis, or Parkinson Disease? Evidence-Based Practice in Palliative Medicine. 2013:317-29.
https://doi.org/10.1016/B978-1-4377-3796-7.00056-2
Lou JS, Reeves A, Benice T, Sexton G. Fatigue and depression are associated with poor quality of life in ALS. Neurology. 2003;60(1):122-3.
https://doi.org/10.1212/01.WNL.0000042781.22278.0A
PMid:12525733
Fateh HR, Askary-Kachoosangy R, Shirzad N, Akbarzadeh-Baghban A, Fatehi F. The effect of energy conservation strategies on fatigue, function, and quality of life in adults with motor neuron disease: Randomized controlled trial. Curr J Neurol. 2022;21(2):83-90.
https://doi.org/10.18502/cjn.v21i2.10491
PMid:38011426 PMCid:PMC9860213
Kos D, Duportail M, Meirte J, Meeus M, D'Hooghe M B, Nagels G, et al. The effectiveness of a self-management occupational therapy intervention on activity performance in individuals with multiple sclerosis-related fatigue: a randomized-controlled trial. Int J Rehabil Res. 2016;39(3):255-62.
https://doi.org/10.1097/MRR.0000000000000178
PMid:27182847
Vanage SM, Gilbertson KK, Mathiowetz V. Effects of an energy conservation course on fatigue impact for persons with progressive multiple sclerosis. Am J Occup Ther. 2003;57(3):315-23.
https://doi.org/10.5014/ajot.57.3.315
PMid:12785670
Mathiowetz VG, Matuska KM, Finlayson ML, Luo P, Chen HY. One-year follow-up to a randomized controlled trial of an energy conservation course for persons with multiple sclerosis. Int J Rehabil Res. 2007;30(4):305-13.
https://doi.org/10.1097/MRR.0b013e3282f14434
PMid:17975450
Matuska K, Mathiowetz V, Finlayson M. Use and perceived effectiveness of energy conservation strategies for managing multiple sclerosis fatigue. Am J Occup Ther. 2007;61(1):62-9.
https://doi.org/10.5014/ajot.61.1.62
PMid:17302106
Lewis M, Rushanan S. The role of physical therapy and occupational therapy in the treatment of amyotrophic lateral sclerosis. NeuroRehabilitation. 2007;22(6):451-61.
https://doi.org/10.3233/NRE-2007-22608
PMid:18198431
Ball L, Beukelman D, Bardach L. AAC intervention for ALS Paul H. Brookes Baltimore. 2007; 43(6):841-78.
Yorkston KM, Beukelman DR, Strand EA, Hakel M. Management of motor speech disorders in children and adults. Pro-ed Austin: TX; 1999.
Beukelman DR, Garrett KL, Yorkston KM. Augmentative communication strategies for adults with acute or chronic medical conditions. Brookes: Pub; 2007.
Tomik B, Guiloff RJ. Dysarthria in amyotrophic lateral sclerosis: A review. Amyotroph Lateral Scler. 2010;11(1-2):4-15.
https://doi.org/10.3109/17482960802379004
PMid:20184513
Pugliese R, Sala R, Regondi S, Beltrami B, Lunetta C. Emerging technologies for management of patients with amyotrophic lateral sclerosis: from telehealth to assistive robotics and neural interfaces. J Neurol. 2022;269(6):2910-21.
https://doi.org/10.1007/s00415-022-10971-w
PMid:35059816 PMCid:PMC8776511
Murphy J. Communication strategies of people with ALS and their partners. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5(2):121-6.
https://doi.org/10.1080/14660820410020411
PMid:15204014
Beukelman D, Fager S, Nordness A. Communication support for people with ALS. Neurol Res Int. 2011;2011:714693.
https://doi.org/10.1155/2011/714693
PMid:21603029 PMCid:PMC3096454
Gelinas D, Miller R. A treatable disease: a guide to the management of amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis London: Martin Dunitz. 2000:405-22.
Bongioanni P. Communication impairment in. ALS patients assessment and treatment: Citeseer; 2012.
PMCid:PMC3463670
Linse K, Aust E, Joos M, Hermann A. Communication matters-pitfalls and promise of hightech communication devices in palliative care of severely physically disabled patients with amyotrophic lateral sclerosis. Front Neurol. 2018;9:603.
https://doi.org/10.3389/fneur.2018.00603
PMid:30100896 PMCid:PMC6072854
Clerc M, Mattout J, Maby E, Devlaminck D, Papadopoulo T, Guy V, et al. Verbal communication through brain computer interfaces. Interspeech-14th Annual Conference of the International Speech Communication Association-2013. 2013; :00842851.
Guy V, Soriani M-H, Bruno M, Papadopoulo T, Desnuelle C, Clerc M. Brain computer interface with the P300 speller: Usability for disabled people with amyotrophic lateral sclerosis. Ann Phys Rehabil Med. 2018;61(1):5-11.
https://doi.org/10.1016/j.rehab.2017.09.004
PMid:29024794
Edughele HO, Zhang Y, Muhammad-Sukki F, Vien Q-T, Morris-Cafiero H, Agyeman MO. Eye-tracking assistive technologies for individuals with amyotrophic lateral sclerosis. IEEE Access. 2022;10:41952-72.
https://doi.org/10.1109/ACCESS.2022.3164075
Calvo A, Chiò A, Castellina E, Corno F, Farinetti L, Ghiglione P, et al. Eye tracking impact on quality-of-life of ALS patients Computers Helping People with Special Needs: 11th International Conference, ICCHP 2008, Linz, Austria, July 9-11, 2008 Proceedings 11. Springer. 2008; :70-78.
Cipresso P, Meriggi P, Carelli L, Solca F, Meazzi D, Poletti B, et al. The combined use of Brain Computer Interface and Eye-Tracking technology for cognitive assessment in Amyotrophic Lateral Sclerosis 2011 5th International conference on pervasive computing technologies for healthcare (PervasiveHealth) and workshops. IEEE. 2011; : 320-324.
https://doi.org/10.4108/icst.pervasivehealth.2011.246018
Ball LJ, Nordness AS, Fager SK, Kersch K, Mohr B, Pattee GL, et al. Eye gaze access of AAC technology for people with amyotrophic lateral sclerosis. J Med Speech-Lang Pathol. 2010;18(3):11.
Paganoni S, Karam C, Joyce N, Bedlack R, Carter GT. Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis. NeuroRehabilitation. 2015;37(1):53-68.
https://doi.org/10.3233/NRE-151240
PMid:26409693 PMCid:PMC5223769
Tabor L, Gaziano J, Watts S, Robison R, Plowman EK. Defining Swallowing-Related Quality of Life Profiles in Individuals with Amyotrophic Lateral Sclerosis. Dysphagia. 2016;31(3):376-82.
https://doi.org/10.1007/s00455-015-9686-2
PMid:26837611 PMCid:PMC4871719
Printza A, Boziki M, Triaridis S, Kiousi V, Arnaoutoglou M, Constantinidis J, et al. Tongue strength, dysphagia questionnaire, pharyngeal secretions and FEES findings in dysphagia management in amyotrophic lateral sclerosis. Auris Nasus Larynx. 2021;48(4):672-82.
https://doi.org/10.1016/j.anl.2020.10.007
PMid:33109427
Muscaritoli M, Kushta I, Molfino A, Inghilleri M, Sabatelli M, Rossi Fanelli F. Nutritional and metabolic support in patients with amyotrophic lateral sclerosis. Nutrition. 2012;28(10):959-66.
https://doi.org/10.1016/j.nut.2012.01.011
PMid:22677356
Palovcak M, Mancinelli JM, Elman LB, McCluskey L. Diagnostic and therapeutic methods in the management of dysphagia in the ALS population: issues in efficacy for the out-patient setting. NeuroRehabilitation. 2007;22(6):417-23.
https://doi.org/10.3233/NRE-2007-22603
PMid:18198426
Dorst J, Cypionka J, Ludolph AC. High-caloric food supplements in the treatment of amyotrophic lateral sclerosis: a prospective interventional study. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(7-8):533-6.
https://doi.org/10.3109/21678421.2013.823999
PMid:23944684
Greenwood DI. Nutrition management of amyotrophic lateral sclerosis. Nutr Clin Pract. 2013;28(3):392-9.
https://doi.org/10.1177/0884533613476554
PMid:23466470
Verschueren A, Monnier A, Attarian S, Lardillier D, Pouget J. Enteral and parenteral nutrition in the later stages of ALS: an observational study. Amyotroph Lateral Scler. 2009;10(1):42-6.
https://doi.org/10.1080/17482960802267480
PMid:18615338
Scott AG, Austin HE. Nasogastric feeding in the management of severe dysphagia in motor neurone disease. Palliat Med. 1994;8(1):45-9.
https://doi.org/10.1177/026921639400800108
PMid:8180740
Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73(15):1218-26.
https://doi.org/10.1212/WNL.0b013e3181bc0141
PMid:19822872 PMCid:PMC2764727
Park JH, Kang SW. Percutaneous radiologic gastrostomy in patients with amyotrophic lateral sclerosis on noninvasive ventilation. Arch Phys Med Rehabil. 2009;90(6):1026-9.
https://doi.org/10.1016/j.apmr.2008.12.006
PMid:19480880
Stavroulakis T, Baird WO, Baxter SK, Walsh T, Shaw PJ, McDermott CJ. Factors influencing decision-making in relation to timing of gastrostomy insertion in patients with motor neurone disease. BMJ Support Palliat Care. 2014;4(1):57-63.
https://doi.org/10.1136/bmjspcare-2013-000497
PMid:24644772
Shoesmith C. Palliative care principles in ALS. Handb Clin Neurol. 2023;191:139-55.
https://doi.org/10.1016/B978-0-12-824535-4.00007-0
PMid:36599506
Diagnosis ETFo, Sclerosis: MoAL, Andersen PM, Abrahams S, Borasio GD, de Carvalho M, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)-revised report of an EFNS task force. Eur J Neurol. 2012;19(3):360-75.
https://doi.org/10.1111/j.1468-1331.2011.03501.x
PMid:21914052
Hess DR. Noninvasive ventilation in neuromuscular disease: equipment and application. Respir Care. 2006;51(8):896-911.
Bourke S, Bullock R, Williams T, Shaw P, Gibson G. Noninvasive ventilation in ALS: indications and effect on quality of life. Neurology. 2003;61(2):171-7.
https://doi.org/10.1212/01.WNL.0000076182.13137.38
PMid:12874394
Mustfa N, Walsh E, Bryant V, Lyall R, Addington-Hall J, Goldstein L, et al. The effect of noninvasive ventilation on ALS patients and their caregivers. Neurology. 2006;66(8):1211-7.
https://doi.org/10.1212/01.wnl.0000208957.88534.11
PMid:16636239
Georges M, Morelot-Panzini C, Similowski T, Gonzalez-Bermejo J. Noninvasive ventilation reduces energy expenditure in amyotrophic lateral sclerosis. BMC Pulm Med. 2014;14(1):17.
https://doi.org/10.1186/1471-2466-14-17
PMid:24507664 PMCid:PMC3922008
Goldberg A. Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation--a. Chest. 1999;116(2):521.
https://doi.org/10.1378/chest.116.2.521
PMid:10453883
Vrijsen B, Testelmans D, Belge C, Vanpee G, Van Damme P, Buyse B. Patient-ventilator asynchrony, leaks and sleep in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(5-6):343-50.
https://doi.org/10.3109/21678421.2016.1170149
PMid:27077786
Antonelli M, Conti G, Pelosi P, Gregoretti C, Pennisi MA, Costa R, et al. New treatment of acute hypoxemic respiratory failure: noninvasive pressure support ventilation delivered by helmet--a pilot controlled trial. Crit Care Med. 2002;30(3):602-8.
https://doi.org/10.1097/00003246-200203000-00019
PMid:11990923
Fiorentino G, Annunziata A, Gaeta AM, Lanza M, Esquinas A. Continuous noninvasive ventilation for respiratory failure in patients with amyotrophic lateral sclerosis: current perspectives. Degener Neurol Neuromuscul Dis. 2018;8:55-61.
https://doi.org/10.2147/DNND.S170771
PMid:30233272 PMCid:PMC6130289
Everett EA, Pedowitz E, Maiser S, Cohen J, Besbris J, Mehta AK, et al. Top ten tips palliative care clinicians should know about amyotrophic lateral sclerosis. J Palliat Med. 2020;23(6):842-7.
https://doi.org/10.1089/jpm.2020.0046
PMid:32101493
Kim HS, Woo H, Choi SJ, Baek JG, Ryu JS, Shin HI, et al. Factors associated with adherence to noninvasive positive pressure ventilation in amyotrophic lateral sclerosis. PLoS One. 2024;19(5):e0302515.
https://doi.org/10.1371/journal.pone.0302515
PMid:38748695 PMCid:PMC11095767
Melo J, Homma A, Iturriaga E, Frierson L, Amato A, Anzueto A, et al. Pulmonary evaluation and prevalence of non-invasive ventilation in patients with amyotrophic lateral sclerosis: a multicenter survey and proposal of a pulmonary protocol. J Neurol Sci.. 1999;169(1-2):114-7.
https://doi.org/10.1016/S0022-510X(99)00228-2
PMid:10540018
Pinto S, De Carvalho M. Is a four-hour use of non-invasive ventilation enough to define compliance? Amyotroph Lateral Scler . 2010;11(1-2):250-2.
https://doi.org/10.3109/17482960903214480
PMid:19722113
Hadjikoutis S, Wiles C, Eccles R. Cough in motor neuron disease: a review of mechanisms. Qjm. 1999;92(9):487-94.
https://doi.org/10.1093/qjmed/92.9.487
PMid:10627867
McHenry KL. Airway Clearance Strategies and Secretion Management in Amyotrophic Lateral Sclerosis. Respir Care. 2024;69(2):227-37.
https://doi.org/10.4187/respcare.11215
PMid:37816542 PMCid:PMC10898456
Jones U, Enright S, Busse M. Management of respiratory problems in people with neurodegenerative conditions: a narrative review. Physiotherapy. 2012;98(1):1-12.
https://doi.org/10.1016/j.physio.2011.03.002
PMid:22265380
Lange D, Lechtzin N, Davey C, David W, Heiman-Patterson T, Gelinas D, et al. High-frequency chest wall oscillation in ALS: an exploratory randomized, controlled trial. Neurology. 2006;67(6):991-7.
https://doi.org/10.1212/01.wnl.0000237439.78935.46
PMid:17000967
Ambrosino N, Carpene N, Gherardi M. Chronic respiratory care for neuromuscular diseases in adults. Eur Respir J. 2009;34(2):444-51.
https://doi.org/10.1183/09031936.00182208
PMid:19648521
Sancho J, Servera E, Díaz J, Marín J. Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis. Chest. 2004;125(4):1400-5.
https://doi.org/10.1378/chest.125.4.1400
PMid:15078752
Funo K, Negishi Y, Akamine C, Takeuchi R, Uzawa Y. Setting Mechanical Insufflation-Exsufflation (MI-E) Pressures for Amyotrophic Lateral Sclerosis (ALS) Patients to Improve Atelectasis and Reduce Risk of Pneumothorax: A Case Report. Cureus. 2022;14(6):e25786.
https://doi.org/10.7759/cureus.25786
PMid:35812619 PMCid:PMC9270190
Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, et al. Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines An evidence-based review with good practice points EALSC Working Group. Amyotroph Lateral Scler. 2007;8(4):195-213.
https://doi.org/10.1080/17482960701262376
PMid:17653917
Morris LL, Whitmer A, McIntosh E. Tracheostomy care and complications in the intensive care unit. Crit Care Nurse. 2013;33(5):18-30.
https://doi.org/10.4037/ccn2013518
PMid:24085825
Spataro R, Bono V, Marchese S, La Bella V. Tracheostomy mechanical ventilation in patients with amyotrophic lateral sclerosis: clinical features and survival analysis. J Neurol Sci. 2012;323(1-2):66-70.
https://doi.org/10.1016/j.jns.2012.08.011
PMid:22989611
Magelssen M, Holmoy T, Horn MA, Fondenaes OA, Dybwik K, Forde R. Ethical challenges in tracheostomy-assisted ventilation in amyotrophic lateral sclerosis. J Neurol. 2018;265(11):2730-6.
https://doi.org/10.1007/s00415-018-9054-x
PMid:30218178
Hayashi N, Atsuta N, Yokoi D, Nakamura R, Nakatochi M, Katsuno M, et al. Prognosis of amyotrophic lateral sclerosis patients undergoing tracheostomy invasive ventilation therapy in Japan. J Neurol Neurosurg Psychiatry. 2020;91(3):285-90.
https://doi.org/10.1136/jnnp-2019-322213
PMid:31937581
Kimura F. [Tracheostomy and invasive mechanical ventilation in amyotrophic lateral sclerosis: decision-making factors and survival analysis]. Rinsho Shinkeigaku. 2016;56(4):241-7.
https://doi.org/10.5692/clinicalneurol.cn-000837
PMid:27025993
Vianello A, Concas A. Tracheostomy ventilation in ALS: a Japanese bias. J Neurol Sci. 2014;344(1):3-4.
https://doi.org/10.1016/j.jns.2014.06.050
PMid:25012483
Turner MR, Faull C, McDermott CJ, Nickol AH, Palmer J, Talbot K. Tracheostomy in motor neurone disease. Pract Neurol. 2019;19(6):467-75.
https://doi.org/10.1136/practneurol-2018-002109
PMid:31273080
Sales de Campos P, Olsen WL, Wymer JP, Smith BK. Respiratory therapies for Amyotrophic Lateral Sclerosis: A state of the art review. Chron Respir Dis. 2023;20:14799731231175915.
https://doi.org/10.1177/14799731231175915
PMid:37219417 PMCid:PMC10214054
Henschke C. Provision and financing of assistive technology devices in Germany: A bureaucratic odyssey The case of amyotrophic lateral sclerosis and Duchenne muscular dystrophy. Health policy. 2012;105(2-3):176-84.
https://doi.org/10.1016/j.healthpol.2012.01.013
PMid:22349416
Brizzi KT, Bridges JFP, Yersak J, Balas C, Thakur N, Galvin M, et al. Understanding the needs of people with ALS: a national survey of patients and caregivers. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21(5-6):355-63.
https://doi.org/10.1080/21678421.2020.1760889
PMid:32396393
Olesen LK, la Cour K, With H, Mahoney AF, Handberg C. A cross-sectional evaluation of acceptability of an online palliative rehabilitation program for family caregivers of people with amyotrophic lateral sclerosis and cognitive and behavioral impairments. BMC Health Serv Res. 2022;22(1):697.
https://doi.org/10.1186/s12913-022-07986-4
PMid:35610609 PMCid:PMC9128325
Olesen LK, la Cour K, With H, Handberg C. Reflections of family caregivers and health professionals on the everyday challenges of caring for persons with amyotrophic lateral sclerosis and cognitive impairments: a qualitative study. Palliat Care Soc Pract. 2022;16:26323524221077702.
https://doi.org/10.1177/26323524221077702
PMid:35187490 PMCid:PMC8855464
de Wit J, Bakker LA, van Groenestijn AC, van den Berg LH, Schröder CD, Visser-Meily JM, et al. Caregiver burden in amyotrophic lateral sclerosis: a systematic review. Palliat Med. 2018;32(1):231-45.
https://doi.org/10.1177/0269216317709965
PMid:28671483 PMCid:PMC5784458
Miller R, Jackson C, Kasarskis E, England J, Forshew D, Johnston W, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73(15):1227-33.
https://doi.org/10.1212/WNL.0b013e3181bc01a4
PMid:19822873 PMCid:PMC2764728
Aoun SM, Connors SL, Priddis L, Breen LJ, Colyer S. Motor Neurone Disease family carers' experiences of caring, palliative care and bereavement: an exploratory qualitative study. Palliat Med. 2012;26(6):842-50.
https://doi.org/10.1177/0269216311416036
PMid:21775409
Hogden A, Foley G, Henderson RD, James N, Aoun SM. Amyotrophic lateral sclerosis: improving care with a multidisciplinary approach. J Multidiscip Healthc. 2017; 10: 205-15.
https://doi.org/10.2147/JMDH.S134992
PMid:28579792 PMCid:PMC5446964
Paganoni S, Macklin EA, Lee A, Murphy A, Chang J, Zipf A, et al. Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS). Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(5-6):453-6.
https://doi.org/10.3109/21678421.2014.903974
PMid:24981792 PMCid:PMC4433003

Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Galen Medical Journal

This work is licensed under a Creative Commons Attribution 4.0 International License.